Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Biocept Inc. (BIOC)

0.32   -0.017 (-4.93%) 01-24 16:00
Open: 0.3333 Pre. Close: 0.3366
High: 0.3365 Low: 0.316
Volume: 2,831,358 Market Cap: 14M
Biocept Inc is an early commercial-stage molecular oncology diagnostics company. It develops and commercializes proprietary circulating tumor cell and circulating tumor DNA assays utilizing a standard blood sample.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 0.34 - 0.342 0.342 - 0.344
Low: 0.315 - 0.317 0.317 - 0.319
Close: 0.316 - 0.319 0.319 - 0.323

Technical analysis

as of: 2020-01-24 4:30:03 PM
Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 0.46     One year: 0.57
Support: Support1: 0.23    Support2: 0.19
Resistance: Resistance1: 0.39    Resistance2: 0.49
Pivot: 0.34
Moving Average: MA(5): 0.34     MA(20): 0.32
MA(100): 0.59     MA(250): 0.89
MACD: MACD(12,26): -0.01     Signal(9): -0.02
Stochastic oscillator: %K(14,3): 25.40     %D(3): 32.14
RSI: RSI(14): 44.02
52-week: High: 2.29  Low: 0.23  Change(%): -84.8
Average Vol(K): 3-Month: 587872  10-Days: 851028

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
BIOC has closed above bottom band by 27.2%. Bollinger Bands are 56.5% narrower than normal. The narrow width of the bands suggests low volatility as compared to BIOC's normal range. The bands have been in this narrow range for 2 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Biocept Announces Validation and Availability of its Liquid Biopsy Platform for the Detection of Actionable Cancer Biomarkers in Cerebrospinal Fluid
SAN DIEGO, Jan. 14, 2020 /PRNewswire/ -- Biocept, Inc. (NASDAQ: BIOC), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of patients diagnosed with cancer, announces that its Target Selector™…

Biocept, Inc. Awarded United States Patent for the Use of Antibodies in Combination with Any Solid Surface to Detect Any Target Cell of Interest - from Any Sample Type
SAN DIEGO, Jan. 8, 2020 /PRNewswire/ -- Biocept, Inc. (Nasdaq: BIOC), a leading commercial provider of molecular offerings designed to provide physicians with clinically actionable information to improve the outcomes of patients diagnosed with cancer, announces that it has been awarded…

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ Capital Market
Sector:  Healthcare
Industry:  Diagnostics Research
Shares Out. (M) 42.22
Shares Float (M) 23.01
% Held by Insiders 0.09
% Held by Institutions 7.55
Shares Short (K) 2230
Shares Short P. Month (K)

Stock Financials

EPS -1.777
Book Value (p.s.) 0.340
PEG Ratio -0.01
Profit Margin
Operating Margin -507.00
Return on Assets (ttm) -100.4
Return on Equity (ttm) -305.7
Qtrly Rev. Growth 100.8
Gross Profit (p.s.) -0.161
Sales Per Share
EBITDA (p.s.) -0.531
Qtrly Earnings Growth
Operating Cash Flow (M) -23.00
Levered Free Cash Flow (M) -14.82

Stock Valuations

P/E -0.18
P/E Growth Ratio -0.06
P/BV 0.94
P/CF -0.59

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date 2018-07-09
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.